| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1From the Departments of Ophthalmology, 2Anatomy and Neurobiology, and 3Genetics, University of Maryland School of Medicine, Baltimore, Maryland.
PURPOSE. Anterior ischemic optic neuropathy (AION) is caused by sudden loss of vascular supply to retinal ganglion cell (RGC) axons in the anterior portion of the optic nerve and is a major cause of optic nerve dysfunction. There has been no easily obtainable animal model of this disorder. The current study was conducted to design a novel model of rodent AION (rAION), to enable more detailed study of this disease.
METHODS. A novel rodent photoembolic stroke model was developed that is directly analogous to human AION. Using histologic, electrophysiological, molecular- and cell biological methods, the early changes associated with isolated RGC axonal ischemia were characterized.
RESULTS. Functional (electrophysiological) changes occurred in RGCs within 1 day after rAION, with a loss of visual evoked potential (VEP) amplitude that persisted in the long term. The retinal gene expression pattern rapidly changed after rAION induction, with an early (<1 day) initial induction of c-Fos mRNA, and loss of RGC-specific gene expression. RGC-specific protein expression declined 2 days after detectable mRNA level changes, and immunostaining suggested that multiple retinal layers react to isolated RGC axonal ischemia.
CONCLUSIONS. rAION rapidly results in electrophysiological and histologic changes similar to clinical AION, with reactive responses in primary and supporting neuronal cell layers. The rAION model can enable a detailed analysis of the individual retinal and optic nerve changes that occur after optic nerve stroke, which may be useful in determining possible therapeutic interventions for this disorder.
This article has been cited by other articles:
|
|
 |
|
  H. F. Edelhauser, J. H. Boatright, J. M. Nickerson, and the Third ARVO/Pfizer Research Institute Working G Drug Delivery to Posterior Intraocular Tissues: Third Annual ARVO/Pfizer Ophthalmics Research Institute Conference Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 4712 - 4720. [Full Text] [PDF]
|
|
|
|
|
|
B. J. Slater, Z. Mehrabian, Y. Guo, A. Hunter, and S. L. Bernstein Rodent Anterior Ischemic Optic Neuropathy (rAION) Induces Regional Retinal Ganglion Cell Apoptosis with a Unique Temporal Pattern Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3671 - 3676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Chen, M. A. Johnson, R. A. Flower, B. J. Slater, N. R. Miller, and S. L. Bernstein A Primate Model of Nonarteritic Anterior Ischemic Optic Neuropathy Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 2985 - 2992. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Jehle, K. Wingert, C. Dimitriu, W. Meschede, J. Lasseck, M. Bach, and W. A. Lagreze Quantification of Ischemic Damage in the Rat Retina: A Comparative Study Using Evoked Potentials, Electroretinography, and Histology Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 1056 - 1064. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Bernstein, Y. Guo, B. J. Slater, A. Puche, and S. E. Kelman Neuron Stress and Loss Following Rodent Anterior Ischemic Optic Neuropathy in Double-Reporter Transgenic Mice Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2304 - 2310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. W. Fraunfelder, H. D. Pomeranz, and R. A. Egan Nonarteritic anterior ischemic optic neuropathy and sildenafil. Arch Ophthalmol, May 1, 2006; 124(5): 733 - 734. [Full Text] [PDF]
|
|
|
|
|
|
N. Goldenberg-Cohen, Y. Guo, F. Margolis, Y. Cohen, N. R. Miller, and S. L. Bernstein Oligodendrocyte Dysfunction after Induction of Experimental Anterior Optic Nerve Ischemia Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2716 - 2725. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
